Skip to main content
Contact
Site Search
Home
About
Who We Are
Leadership
Our Legacy
Science
Overview
Publications
Pipeline
Overview
Clinical Trials
Patients
Therapeutic Focus
Patient Resources
Access Policy
News/Events
Overview
Press Releases
Events & Presentations
Email and News Alerts
Careers
Overview
Our Values
Inside Momenta
Benefits
Search Openings
Home
About
Who We Are
Leadership
Our Legacy
Science
Overview
Publications
Pipeline
Overview
Clinical Trials
Patients
Therapeutic Focus
Patient Resources
Access Policy
News/Events
Overview
Press Releases
Events & Presentations
Email and News Alerts
Careers
Overview
Our Values
Inside Momenta
Benefits
Search Openings
Press Releases
Home
>
News/Events
>
Press Releases
Normal
Press Release RSS Feed (opens in new window)
Press release year list
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
11/29/2016
Momenta Pharmaceuticals Announces Positive Top-Line Phase 3 Results for M923, a Proposed HUMIRA® (adalimumab) Biosimilar
Download
PDF format download (opens in new window)
11/17/2016
Momenta Pharmaceuticals Announces Publication on the Design of M230, a Novel Autoimmune Disease Drug Candidate, in Science Translational Medicine
Download
PDF format download (opens in new window)
11/02/2016
Momenta and Mylan Initiate Phase 1 Clinical Trial for M834, a Proposed Biosimilar of ORENCIA® (abatacept)
Download
PDF format download (opens in new window)
11/02/2016
Momenta Pharmaceuticals Appoints Scott M. Storer as Senior Vice President and Chief Financial Officer
Download
PDF format download (opens in new window)
11/02/2016
Momenta Pharmaceuticals Reports Third Quarter 2016 Financial Results
Download
PDF format download (opens in new window)
10/31/2016
Momenta Pharmaceuticals to Webcast at Two Upcoming Investor Conferences
Download
PDF format download (opens in new window)
10/20/2016
Momenta Pharmaceuticals Announces Date for Third Quarter 2016 Financial Results Conference Call and Webcast
Download
PDF format download (opens in new window)
09/27/2016
Momenta Pharmaceuticals to Regain Global Development and Commercialization Rights to M923, a Proposed Biosimilar of HUMIRA® (adalimumab), Through Termination of Collaboration Agreement with Baxalta, Now Part of Shire
Download
PDF format download (opens in new window)
09/23/2016
Momenta Pharmaceuticals Appoints Corey N. Fishman to Board of Directors
Download
PDF format download (opens in new window)
08/31/2016
Momenta Pharmaceuticals to Webcast Presentation at the 2016 Wells Fargo Healthcare Conference
Download
PDF format download (opens in new window)
08/04/2016
Momenta Discontinues Further Accrual of its Phase 2 Trial of Necuparanib in Patients with Pancreatic Cancer Following Planned Interim Futility Analysis
Download
PDF format download (opens in new window)
08/04/2016
Momenta Pharmaceuticals Reports Second Quarter 2016 Financial Results
Download
PDF format download (opens in new window)
07/21/2016
Momenta Pharmaceuticals Announces Date for Second Quarter 2016 Financial Results Conference Call and Webcast
Download
PDF format download (opens in new window)
06/23/2016
Momenta Pharmaceuticals Appoints Steven C. Gilman, Ph.D. to Board of Directors
Download
PDF format download (opens in new window)
06/09/2016
Momenta Pharmaceuticals Initiates Phase 1 Trial of M281, an Anti-FcRn Monoclonal Antibody
Download
PDF format download (opens in new window)
06/08/2016
Momenta Pharmaceuticals Announces Data Presentation on M923, a Proposed HUMIRA® (adalimumab) Biosimilar, at EULAR 2016
Download
PDF format download (opens in new window)
06/04/2016
Momenta Pharmaceuticals Announces Presentation of Final Data from Phase 1 Trial of Necuparanib in Patients with Pancreatic Cancer at ASCO
Download
PDF format download (opens in new window)
05/25/2016
Momenta Pharmaceuticals to Webcast Presentation at the Goldman Sachs 37th Annual Global Healthcare Conference
Download
PDF format download (opens in new window)
05/19/2016
Momenta Pharmaceuticals Announces Data Presentation on Necuparanib at the 2016 ASCO Annual Meeting
Download
PDF format download (opens in new window)
05/03/2016
Momenta Pharmaceuticals Reports First Quarter 2016 Financial Results
Download
PDF format download (opens in new window)
04/26/2016
Momenta Pharmaceuticals Announces Time Change for First Quarter 2016 Financial Results Conference Call and Webcast
Download
PDF format download (opens in new window)
04/25/2016
Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences
Download
PDF format download (opens in new window)
04/19/2016
Momenta Pharmaceuticals Announces Date of First Quarter 2016 Financial Results Conference Call and Webcast
Download
PDF format download (opens in new window)
03/09/2016
Momenta Pharmaceuticals Appoints Jose-Carlos Gutierrez-Ramos, Ph.D. to Board of Directors
Download
PDF format download (opens in new window)
02/24/2016
Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences
Download
PDF format download (opens in new window)
02/18/2016
Momenta Pharmaceuticals Reports Fourth Quarter and Year End 2015 Financial Results
Download
PDF format download (opens in new window)
02/10/2016
Momenta Pharmaceuticals Announces Early HSR Clearance for Biosimilars Collaboration With Mylan
Download
PDF format download (opens in new window)
02/05/2016
Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2015 Financial Results Conference Call and Webcast
Download
PDF format download (opens in new window)
02/01/2016
Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences
Download
PDF format download (opens in new window)
01/08/2016
Momenta Pharmaceuticals Announces Worldwide Collaboration With Mylan to Jointly Develop and Commercialize Six Biosimilar Products
Download
PDF format download (opens in new window)
01/05/2016
Momenta Pharmaceuticals to Webcast Presentation at the 34th Annual J. P. Morgan Healthcare Conference
Download
PDF format download (opens in new window)